Zomedica Corp. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Zomedica Corp. (ZOMDF) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $2.58 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-05
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.58M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $3.88M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.39M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.79M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $2.58M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.88M 10-Q · filed 2026-05-06 |
| 2025-09-30 | $1.39M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $2.79M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.19M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $1.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.22M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.84M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $1.58M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.65M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.73M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $1.05M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.54M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.21M 10-Q · filed 2022-05-10 |
| 2020-09-30 | $46.01K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $90.80K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $134.80K 10-Q · filed 2020-05-11 |